Research in plant biotechnology is playing a crucial role in the production and conservation of plant-based resources globally. Being a country with rich and diverse floral resources, South Africa has a genuine opportunity to develop efficient and competitive plant biotechnology sectors. South Africa has a policy framework, in the form of a National Biotechnology Strategy that supports biotechnology research. The presence of competitive research infrastructure coupled with the government's willingness to commit significant resources will certainly help realise this. South Africa's plant biotechnology research has potential to make more significant contributions to the national economy. In this review, whilst highlighting the success, the research endeavours, prospects and challenges hindering the practical application of micropropagation research outputs are discussed.
Introduction
According to the United Nations Environment Programme (UNEP) Convention on Biological Diversity, biotechnology is defined as a body of techniques that use biological systems, living organisms, or derivatives thereof to make or modify products or processes for specific use (UNEP, 1992) . This definition is also adopted by the South African Biotechnology Strategy (DST, 2001) . Although biotechnology is perceived as a modern science, the above definition shows that it is an old science which has been used for many years. The use of fermentation agents in breweries and bakeries, processing of dairy products, development of new animal breeds and crop cultivars have all used living organisms to improve or modify a product, hence fully satisfying the definition. The discovery of DNA and development of gene technologies however, gave biotechnology a new dimension giving it a modern look.
Despite its rich history of using biotechnology, South Africa has not fully exploited the full benefits of the recent advances in biotechnology which triggered the need for a national biotechnology strategy to make up for lost ground (DST, 2001 ). Ten years have elapsed since the adoption of the National Biotechnology Strategy. This review aims to assess the research endeavours, economic prospects and challenges of plant biotechnology research in South Africa with special emphasis on the use of plant tissue culture in the propagation, conservation, commercialization as well as improvement of economically important plant species. Although biotechnology of food crops is briefly discussed, most emphasis is given to research on the biotechnology of non-food plants.
Plant biotechnology research in South Africa
Biotechnology research and its application in South Africa are not very far behind when compared to the world's developed countries. One could even argue that the country is progressing well given the fact that it was politically isolated from the international community for many years which resulted in excessive reliance on local innovations (Cloete et al., 2006) . In as much as the reliance on domestic technology contributed to the country's economy and innovation, it appears that only few sectors such as mining, chemical and military were given national priority and little emphasis was given to plant biotechnology (Ofir, 1994) . This however, changed since the year 2000 when the South African government made biotechnology one of its main research focus areas by significantly increasing its support (Cloete et al., 2006) Biotechnology Regional Innovation Centres (BRICs) to act as nuclei for the creation of essential biotechnology platforms was a key step. The strategy also addresses issues such as funding, human resource development, regulatory and legal issues as well as trying to close the gap between research and commercialization (Cloete et al., 2006) . These BRICs recently formed the Technology Innovation Agency (TIA) under the National System of Innovation (NSI) (DST, 2009) .
Micropropagation, conservation and commercialization-based research on the biotechnology of plants are relatively new in South Africa. The past couple of decades however, witnessed a boom in research outputs on biotechnology of plants. This is mainly due to the following important interrelated factors:
1. The need to maximise food productivity; 2. Acknowledgement of the concept of indigenous knowledgethere is a strong relationship between the history of the people of South Africa and the traditional use of plants. This rich history and knowledge of plant use is serving as the foundation for cutting edge biomedical research ranging from the characterization and isolation of active principles to their mass production in vitro using bioreactor systems; 3. Environmental issues -due to the impact of fossil fuel on the environment, the use of plants as a substitute to fossil fuel is gaining popularity. This has resulted in an increase in research endeavours geared towards realising the potential of plants as a source of environmentally friendly energy; 4. Availability of rich floral resources -southern Africa is amongst the richest regions of the world in floral diversity with about 30 000 species of higher plants (Goldblatt, 1978) , many of which are traditionally used for various purposes. South Africa, with less than 2% of the world land surface, is endowed with an estimated 10% of plant species (SANBI, 2011) . Biotechnology has emerged as an essential tool to realise the full economic potential of these rich floral resources through various laboratory-based techniques; for instance the production of secondary metabolites in vitro for the pharmaceutical and cosmetic industries using bioreactor systems and research associated with it; 5. The need for conservation -the growing world population has resulted in an increase on the demand of plants for food, energy, cosmetic and pharmaceutical uses, which in turn exerted huge pressure on wild populations of plants. Such consumption-driven pressure coupled with unsustainable use of plants has warranted the need for urgent conservation measures. Plant tissue culture is playing a key part in this regard; especially for plants that are difficult to propagate as well as those that have lost their natural pollinators due to habitat loss.
Target areas of plant biotechnology research
Research activities in biotechnology can have an impact on industries involved in the agricultural, horticultural, environmental, pharmaceutical and medical sectors. Despite its potential, emphasis on the adoption, diffusion and regulation of plant biotechnology remained largely in the area of agricultural biotechnology with the other sectors still in their infancy (Andanda, 2009) . Nonetheless, compared to other African countries, South Africa is producing high outputs in the fields of plant tissue culture, molecular biology, genetic transformation and conservation of endangered plant species.
The main focus area of this review is research in plant tissue culture. However, the world class research outputs by the various South African universities and research institutions in molecular marker development, genetic fingerprinting, genetic manipulation as well as gene expression profiling and gene discovery of economically important plants such as potato, sugarcane, eucalyptus, maize, soybean, wheat, amongst others are worth mentioning.
Research in plant tissue culture and its associated applications such as genetic transformation constitute one of the major areas of plant biotechnology research in South Africa. Its primary objectives are to increase food productivity, conservation, promotion of sustainable use and commercialization, production of secondary metabolites, understanding the growth requirements of plants as well as development of molecular markers (Bornman et al., 2004; Botha et al., 2004; Okole and Odhav, 2004; Berjak et al., 2011) . Although there is no defined pecking order as far as the target areas of research in non-food plant biotechnology research goes, it appears from recent publications that in vitro conservation of endangered and recalcitrant species (Berjak et al., 2011) as well as propagation of medicinal and ornamental bulbs (Fennell and Van Staden, 2004) are receiving significant attention.
Conservation of plant biodiversity
South Africa is characterized by a population known for excessive reliance on its plant resources for food, medicine, cultural and spiritual demands. Trading plant parts in urban and semi-urban streets is one of the peculiar features of South Africa. Unfortunately, the harvesting and trading of plants is not fully regulated and/or controlled hence lacking sustainability. As a result, there is a need to introduce corrective and protective measures. One such measure was to determine the conservation status of individual plant species -commonly referred to as the National Red List of South African Plants. The Red List is used as a resource for conservation-based research as well as for formulating laws and policies on the harvesting, marketing and use of plants in need of protection. It is being used extensively by scientists whose focus area is in vitro and in situ conservation.
The development of plant biotechnology in general, and plant tissue culture techniques in particular, have changed the face of conservation of genetic resources. The past half a century witnessed the development of countless plant cell and tissue culture techniques and protocols which undoubtedly has rescued many species from extinction. South African research is contributing its share by developing biotechnology-based propagation and conservation methods. Such methods include in vitro propagation of endangered and recalcitrant species, slow growth storage, cryopreservation, in vitro production of secondary metabolites to reduce the pressure on wild population and reintroduction of rare species to natural habitats. Such practises are complimenting the traditional in situ conservation endeavours.
Commercialization
Commercialization of plants and their secondary metabolites is one of the major driving forces behind the advancement of plant biotechnology research in South Africa. Obviously, the commercialization of plant products should be preceded by evaluation of species for the presence of target substances and product development. In addition to its role in plant conservation, research in plant biotechnology is playing an important role in adding value to South Africa's floristic resources. Protecting wild plant populations from over-exploitation, maintaining the gene pool through clonal propagation of superior species and ease of marketing (transport and handling) of plant material are some of the benefits biotechnology research is offering to commercialization (Okole and Odhav, 2004 ).
Growth, physiology and molecular biology
Once a plant is identified as a target of research for conservation or commercialization purposes or both, understanding its growth requirements and genetics are of paramount importance. As a result, research geared towards understanding the growth, physiology and molecular biology of plants is amongst the main target areas of research in South Africa. Tissue culture techniques provide easy, reliable and reproducible approaches for such research due to the possibility to manipulate and control sources of variation. In addition, specialised experiments such as assessing the plants' ability for the production of secondary metabolites in vitro can be done. Table 1 provides an example of some plants that have been studied in South Africa. Tissue culture experiments have also been complimented by genetic fidelity studies using molecular techniques to ensure genetic uniformity of regenerants.
Universities and research institutions
Unlike other African countries, South Africa has the features of both the developed and developing worlds (Al-Bader et al., 2009) . Its universities and research institutions have advanced research facilities and systems. South Africa also has universities comparable with the best in the world; the University of Cape Town for example, was ranked 161 in the world in the year 2010 (QS World University Ranking, 2010). Most universities in South Africa either have dedicated research centres for biotechnology or provide biotechnology training at both under-and post-graduate levels.
In addition to the universities, the country has well established research institutions such as the Agricultural Research Council (ARC), Medical Research Council (MRC) Van Staden (1993, 1995) , Sparg et al. (2002) , Malabadi and Van Staden (2003 , 2005a , 2005b and Nigro et al. (2004b Nigro et al. ( , 2008 Bailey and Bechet (1989) , Snyman et al. (1996 Snyman et al. ( , 2000 Snyman et al. ( , 2001 Snyman et al. ( , 2006 Snyman et al. ( , 2007 Snyman et al. ( , 2008b and Council for Scientific and Industrial Research (CSIR). These universities and research institutions play a pivotal role in the biotechnological development of the country (Cloete et al., 2006) . The presence of a dedicated research institute for agricultural crops, the ARC, seemingly helped universities and other research institutions to focus more on non-food plant biotechnology research. In addition, there are also numerous private commercial companies engaged in plant biotechnology research and production. Some examples of private commercial companies include, the Institute for Commercial Forestry Research (ICFR), the South African Sugar Research Institute (SASRI), Du Roi Laboratories, Panat, Hadeco and African Biotechnologies Limited. An overview of research endeavours, economic prospects and challenges of the South African plant tissue culture-based research and the utilisation of research outputs are discussed in the following sections.
Research endeavours and prospects
South Africa is endowed with an enormous and unique plant biodiversity, which includes high value ornamental, medicinal, aromatic, herbal, and wild food plants. The biodiversity in South Africa accounts for 10% of the global plant species, and is characterized by high levels of endemism (Goldblatt, 1978; Berjak et al., 2011; SANBI, 2011) . These plants are utilised by communities contributing significantly to the local economies, for example, about 80% of the population in South Africa rely on medicinal plant products. The high and increasing demand of plants for medicinal purposes has resulted in the dwindling and sometimes extinction of some species at an unprecedented rate due to over-harvesting. The Red Data List (2009) classified 32 plant taxa as being extinct with a further 1153 species teetering on the "critically endangered" to "endangered" categories, whilst 1227 and 164 species are classified as "rare" and "critically rare", respectively (Berjak et al., 2011) . This worrying trend in the status of biodiversity in South Africa has, in recent times, led to more concerted research efforts in plant conservation. However, until recently, ex situ conservation of wild, rare and endangered species had been negated in favour of crop species (Engelmann, 2011) . Amongst other strategies such as in situ conservation, the role of biotechnological applications in plant conservation, specifically in vitro or tissue culture techniques, have continued to receive increased attention. Engelmann (2011) argues that, though ex situ techniques can be used to complement in situ methods, they may represent the only option for the conservation of highly endangered and rare species. This calls for an urgent need to develop optimal techniques for the medium to long-term storage and rapid multiplication of both crop and wild species of economic importance. However, despite the availability of plant biotechnology facilities and expertise in South Africa, the technology remains largely under-utilised in the conservation of indigenous plant genetic resources (Berjak et al., 2011) . The use of in vitro technology offers practical applications for plant genetic conservation of rare and endangered species, recalcitrant seed and vegetatively propagated species, and biotechnology products such as elite genotypes and genetically engineered crops (Engelmann, 2011) . 
The notation n/a stands for not applicable. 
Indigenous medicinal plants
It is estimated that more than 80% of the population in developing countries is primarily dependent on herbal medicines for basic healthcare needs. In addition, one-fourth of all prescribed pharmaceuticals contain compounds that are directly or indirectly derived from plants (Oksman-Caldentey and Inze', 2004) . Furthermore, 11% of the 252 pharmaceutical drugs considered as basic and essential by the World Health Organisation are synthesised from plants (Rates, 2001 ). The high demand on medicinal plants has led to loss of genetic diversity, local extinctions and habitat degradation in some places (Canter et al., 2005) . Micropropagation protocols have been developed over the past few decades for numerous medicinal plant species, some of which are near extinct, rare or critically endangered (Table 1 ). In particular, research efforts by Universities, Research institutions such as CSIR and ARC, and private laboratories, have made a major contribution in this regard. As stated by Ascough and Van Staden (2010) , the Research Centre for Plant Growth and Development (RCPGD), University of KwaZulu-Natal has successfully conducted micropropagation research of indigenous plant species that are used for medicinal purposes. To date this research group has developed tissue culture protocols for over 150 plant species as part of its postgraduate training programme. The Forestry and Agricultural Biotechnology Institute (FABI) at the University of Pretoria is also contributing significantly in research and postgraduate training in biotechnology and genetics of forest and agricultural crops. Similar efforts on germplasm conservation of both medicinal and other species of economic importance have focussed on cryopreservation strategies using in vitro, cold and ultra-cold technologies (reviewed by Berjak et al., 2011) . Several in vitro propagation protocols were developed for critically endangered and possibly extinct species (Crouch and Van Staden, 1994) , critically endangered species (Ault, 1995b; McAlister et al., 1998a; McCartan and Van Staden, 2003; Taylor et al., 2005; Amoo et al., 2011) , endangered species (Mycock et al., 1997; McCartan and Crouch, 1998; Chukwujekwu et al., 2002; Bairu et al., 2007; Koetle et al., 2010) , vulnerable species (Cook et al., 1988; Van Staden et al., 1991; Finnie et al., 1994; Hannweg et al., 1996; Mycock et al., 1997; Pérez-Francés et al., 2001a; Madubanya et al., 2006) , near threatened species Rabe and Van Staden, 1999) , and declining species (Finnie and Van Staden, 1989; Slabbert et al., 1993 Slabbert et al., ,1995 Ault, 1995a; Appleton and Van Staden, 1995; Van Staden, 2001b, 2001c) . However, a comprehensive approach to the conservation of plant germplasm using in vitro technology should include the optimization of both micropropagation and cryogenic protocols. Such a dual-pronged approach will enable both the storage and propagation of the species.
Production of secondary metabolites
Apart from primary metabolites, higher plants also synthesise a range of secondary metabolites, which are low molecular weight compounds. Plant secondary metabolites are compounds that have no functional role in the maintenance of fundamental physiological and biochemical processes in the plants that synthesise them, but protect the plants in their interaction with the environment (Oksman-Caldentey and Inze ', 2004) . Plant tissue culture provides valuable tools for harnessing secondary metabolites because cells are biosynthetically totipotent and, thus have the genetic capacity to synthesise the same range of chemicals inherent in the parent plant. In addition, novel compounds can also be synthesised through biotransformation (Shanks and Morgan, 1999) . Hence, Ramachandra Rao and Ravishankar (2002) highlighted that plant biotechnology offers the opportunity to exploit in vitro cell, tissue and organ culture and to genetically manipulate them to produce the desired secondary metabolites. The option of using plant cell cultures continues to gain prominence because chemical synthesis of plant-derived compounds is often not economically feasible due to the high complexity of their structures and specific stereochemical requirements (Oksman-Caldentey and Inze ', 2004) . Secondly, many of the plant species endowed with these compounds are difficult to cultivate or have become endangered because of nonsustainable harvesting practises (Oksman-Caldentey and Inze ', 2004) .
In certain instances, secondary metabolites are only produced in organ cultures such as hairy roots. Thus, the ability of Agrobacterium rhizogenes to induce hairy roots in a range of plants has been exploited as a source of root-derived pharmaceutical compounds. Hairy roots are characterized by high growth rates, high proliferation in plant growth regulator-free medium, high branching, genetic and biochemical stability, and production of secondary metabolites over a long time period (Flores et al., 1999; Shanks and Morgan, 1999; Guillon et al., 2006) . Transformation of plant roots with A. rhizogenes today is a commonly used technique to amplify in vitro production of secondary metabolites (Matkowski, 2008) . Colling et al. (2010a) for example, transformed Pelargonium sidoides with rol genes and established highly regenerative transgenic root clones, which produced commercially important coumarins, flavonoids and phenolic acids at significantly high concentrations. The authors concluded that the system has potential as an in vitro conservation system for this medicinally important South African plant.
Secondary metabolites can also accumulate when in vitro cultures are subjected to chemical stimuli and/or environmental stress conditions (Nigro et al., 2004a; Oksman-Caldentey and Inze', 2004) . Triterpenoid saponins were quantified in undifferentiated cultures (callus, cell suspensions) and leaves of in vitro Centella asiatica cultures (James et al., 2008) . Biosynthesis of L-canavanine, a secondary metabolite in Sutherlandia frutescens, was produced in significant concentrations by manipulating environmental factors such as water stress, nitrogen levels and salinity (Colling et al., 2010b; Shaik et al., 2011) . The aromatic medicinal plant, Salvia stenophylla, was induced to produce volatile compounds, including α-bisabolol, an important compound in the cosmetic industry, by manipulating the in vitro microenvironment (Musarurwa et al., 2010) . These recent findings in in vitro secondary metabolite production support previous work done on other South African plant species, such as Oxalis reclinata (Crouch et al., 1993; Makunga et al., 1997) , Bowiea volubilis (Finnie et al., 1994) , Crinum moorei (Fennell et al., 2003) , Eucomis autumnalis Van Staden, 2001b, 2001c) , and Salvia chamelaegnea (Huang and Van Staden, 2002) .
In some cases in vitro produced secondary metabolites have been evaluated for pharmacological activities. Van Staden (2001b, 2001c) reported on the high anti-inflammatory activities of Eucomis autumnalis in vitro extracts against cyclooxygenase (COX)-1 and -2 enzymes. Similarly, hairy root extracts of Maytenus senegalensis induced through Agrobacterium-mediated transformation exhibited slightly higher antibacterial activities compared to untransformed root extracts (Jain et al., 2008) . Recently, Ncube et al. (2011) demonstrated that the antibacterial activity of in vitro and wild Tulbaghia violacea extracts were equally effective.
Over the past two decades the concept of plant-based production of high-value pharmaceutical proteins such as vaccines and antibodies has received growing research interest, and offers critical advantages over traditional bacterial or mammalian cell-based systems (Rybicki, 2010; Xu et al., 2011) . The production of recombinant proteins using either whole-plants (Chikwamba et al., 2002) or in vitro plant cell cultures commonly known as molecular farming is emerging as a promising prospect for the pharmaceutical industry. The major advantages of plant cell cultures in this regard pertains to the consistency of protein products, rapid proliferation of cell cultures, low risk of pathogen contamination associated with mammalian and bacterial systems, and fewer regulatory, environmental and safety compliance mandates (Shih and Doran, 2009 ). However, research efforts are still required to solve technological bottlenecks associated with scaling-up of flask-based plant cell cultures to industrial bioreactors (Xu et al., 2011) and increasing the yield of proteins (Shih and Doran, 2009 ). The emergent research area of molecular farming in the production of valuable pharmaceuticals has been recently reviewed by Shih and Doran (2009) Rybicki (2010) and Xu et al. (2011) .
Floriculture and ornamental plants
Mankind has always been fascinated by flowers. The contagious effects of flowers emanating from their beauty and aesthetic value has, over the centuries, led to domestication, cultivation, selection and breeding of desired traits, in the process metamorphosising floriculture into a global multi-billion dollar industry. According to Bester et al. (2009) , the global value of floriculture products is estimated to be in excess of US$9 billion per annum. The southern Africa region has made a significant contribution to this worldwide flower market by providing floral variety that is inherent in its unique genetic diversity. In particular, South Africa's Cape Floral Kingdom, which displays a spectacular floral show in spring, has over 8500 indigenous flowering species (Van Vuuren, 1995; Bester et al., 2009 ) out of a total of more than 30,000 in the southern Africa region (Fennell and Van Staden, 2004) . This tremendous floral wealth has continued to attract attention of botanists, horticulturists and plant enthusiasts, resulting in many species with ornamental potential being taken from South Africa. These plants have been bred into numerous cultivars and are now widely cultivated in many places such as Europe, USA, China, Australia and New Zealand (Van Vuuren, 1995) . For example, nearly all of the 280 Pelagornium species, which are amongst the most economically important bedding and pot plants in North America and Europe have their origins in South Africa (reviewed by Mithila et al., 2001 ). Several of these South African plants are amongst the top 10 flower species on the European floriculture market (Bester et al., 2009) . Amongst the most important economic species are those belonging to the families Amryllidaceae (e.g. Crinum spp.), Hyacianthaceae (e.g. Eucomis spp., Lanchenalia spp., Ornithogalum spp.), Iridaceae (e.g. Watsonia spp., Babiana spp., Gladiolus spp., Iris spp.,) and Proteaceae (e.g. Protea spp., Leucospermum spp., Leucadendron spp.).
Plant tissue culture and its related biotechnology techniques have made significant contributions in the growth of the floriculture industry through mass micropropagation of healthy plantlets and the facilitation of molecular breeding applications. In vitro propagation protocols have been developed for several species with ornamental and/or floriculture potential, for example, Eucomis spp. (Ault, 1995a; Cheesman et al., 2010) , Babiana spp. (McAlister et al., 1998b) , Lanchenalia spp. (Nel, 1983; Niederwieser and Vcelar, 1990; Niederwieser and Van Staden, 1990, 1992; Ault, 1995b; Slabbert and Niederwieser, 1999) , Ornithogalum spp. (Hussey, 1976; Van Rensburg et al., 1989; De Villiers et al., 2000; Malabadi and Van Staden, 2004) , Protea spp. (Van Staden et al., 1981; Rugge, 1995; Pérez-Francés et al., 2001a , Watsonia spp. (Ascough et al., 2007) . The use of tissue culture-based technologies has facilitated the rapid multiplication of valuable clones, such as Clivia spp., which would otherwise mature from seed to flowering in 3-7 years (Kim and De Hertogh, 1997; Ran and Simpson, 2005) . The use of micropropagation and related biotechnologies was reviewed for ornamental flowering bulbs (Kim and De Hertogh, 1997; Fennell and Van Staden, 2004) , Hyacinthaceae (McCartan and Van Staden, 1999) , ornamental geophytes (Ascough et al., 2008) , Iridaceae (Ascough et al., 2009) , and the genera Lanchenalia and Ornithogalum (Niederwieser, 2004) .
Forest biotechnology
Eucalyptus and conifer species, namely, Pinus and Picea and their hybrids, are important commercial forestry trees, which are used for a wide variety of products in the timber, pulp and pharmaceutical industries. Conifers, which are characterized by long regeneration cycles and short juvenility periods, are openpollinated, heterozygous and exhibit severe inbreeding depression (Bornman, 2002) . This makes conventional breeding longterm and difficult as plant breeders strive to meet the growing demand for commercial forestry with superior growth potential. In vitro biotechnology systems offer the ability to produce new elite genotypes through the processes of mutagenesis, somaclonal variation and genetic engineering as well as the mass propagation of clones (Hajari et al., 2006) . In vitro propagation also fixes the genotype of the donor material in terms of the desired traits, thereby offering the most reliable means of utilising genetic gain (Bornman, 2002) . The most common method of micropropagation of most Eucalyptus and conifer species is based on shoot proliferation on semi-solid medium systems (McAlister et al., 2005 ; see reviews by Le Roux and Watt et al., 2003b) . However, despite the success of semi-solid systems in terms of multiplication yield, the demand for improved productivity within the shortest possible time remains a major requirement. McAlister et al. (2005) reported a four-to-six fold increase in shoot multiplication of Eucalyptus clones using the temporary immersion bioreactor (RITA®) compared to the conventional semi-solid system. The plantlets produced in the RITA® system were also of comparatively better quality, which exhibited superior acclimatisation competence (McAlister et al., 2005) .
Despite some major achievements in Eucalyptus and conifer micropropagation (Watt et al., 1991 (Watt et al., , 2000a (Watt et al., , 2000b (Watt et al., , 2003b Van Staden, 1993, 1994; Meyer, 1998; Sparg et al., 2002; Bornman, 2002; Mokotedi et al., 2003; Van Staden, 2003, 2005a; McAlister et al., 2005; Hajari et al., 2006) , there has been limited success using direct and indirect organogenesis from mature plants due to their recalcitrant nature (Bornman, 2002) . In recent times, the focus on forestry biotechnology research has attempted to harness the potential offered by somatic embryogenesis (Malabadi and Van Staden, 2005a) and synthetic seed technology (Malabadi and Van Staden, 2005b ; and reviewed by Bornman, 2002) . Both technologies offer exciting prospects for propagation of elite genotypes and genetically engineered plants, and germplasm conservation through cryogenic storage, both short to medium term and long-term (Rai et al., 2009 ). However, low conversion of encapsulated propagules into plants remains one of the major obstacles in the commercial application of this technology (Bornman, 2002; Rai et al., 2009) , hence the need for more research efforts in this area.
Food plants
The application of in vitro biotechnology in food plants has mainly been geared towards increasing productivity by facilitating crop breeding endeavours, to meet the food requirements of the ever-growing human population. Classical micropropagation still remains an important technique for certain food plants such as Musa and Saccharum spp. According to Bairu et al. (2008) , bananas, which are an important source of carbohydrates in the tropical and subtropical regions, are one of the most studied plants in the field of tissue culture-based technologies. In vitro culture systems have been critical for the rapid mass propagation of high quality banana propagules. South Africa has commercial laboratories such as Du Roi Laboratories and African Biotechnologies Limited specialising in mass clonal propagation of selected banana cultivars.
In South Africa, another intensively studied food plant using in vitro technology is the genus Saccharum (e.g. Bailey and Bechet, 1989; Meyer et al., 2009; Snyman et al., 2007 Snyman et al., , 2008b Ramgareeb et al., 2010) . In vitro culture techniques using organogenic and somatic embryogenesis have been widely exploited for the mass propagation of elite genotypes and for facilitating genetic engineering processes (reviewed by Snyman et al., 2008a Snyman et al., , 2011a Snyman et al., , 2011b . High frequency plant regeneration has become a prerequisite for most transformation and transgenic applications. In cereals and other crops, the in vitro culture step exhibits strong genotypic dependence (O'Kennedy et al., 2004a (O'Kennedy et al., , 2004b , hence the requirement to optimise specific protocols. Plant regeneration protocols for facilitating plant breeding and transgenic technology have been reported for Pennisetum glaucum (O'Kennedy et al., 2004b) , Triticum aestivum (Ascough et al., 2006) , Saccharum spp. (Snyman et al., 1996 (Snyman et al., , 2000 (Snyman et al., , 2001 (Snyman et al., , 2006 Ferreira et al., 2008) and Zea mays (O'Kennedy et al., 2001; Jäger et al., 2010) .
Integrating biotechnology procedures, such as in vitro androgenesis into current breeding programmes will shorten cultivar development time and also create genetically homozygous inbred lines (Ascough et al., 2006) . Androgenesis involves the development of a haploid sporophyte from gametophytic pollen. In vitro androgenesis has become an indispensable technique for producing both haploid and double haploid plants in a quick, efficient and dependable way. The technology, which has mainly been exploited in cereal and other conventional food crops, has enormous potential in tree species (Srivastava and Chaturvedi, 2008) , such as Sclerocarya birrea, to circumvent outbreeding, heterozygosity and their long regeneration cycles, thereby producing homozygous pure lines. However, success in the application of genetic engineering techniques in plant breeding also relies on the availability of a diverse genetic pool. In recent times, germplasm conservation research of food crops has been focussed on ex situ cryogenic technology (reviewed by Berjak et al., 2011) to complement in situ methods. Several cryogenic protocols are available for food crops, for example, Coffea arabica (Mycock et al., 1995) , Manihot esculanta (Mycock et al., 1995) , and Saccharum spp. (Watt et al., 2009) .
The biotechnological research endeavours discussed above are only examples and do not represent the national output. The prospects for economic growth are clear and can be realised through investment in research and development. In addition to the strategic plan and policy interventions, the government's positive outlook and support to the plant biotechnology initiative is demonstrated by the funding provided to the various research institutions. However, the realisation of the full economic prospects of the plant biotechnology initiative in South Africa is hindered by the challenges outlined in the following sections.
Challenges
One of the core objectives of the planning and adoption of the National Biotechnology Strategy in South Africa was to convert the values of the high quality research output of universities and research institutions to national economic development. This however, has not been achieved as required due to a multitude of factors. Cloete et al. (2006) mentioned the lack of entrepreneurial culture amongst South African researchers associated mainly with the cost of registering foreign patents. In addition, challenges related to technological factors, socioeconomic factors, public perception of biotechnology, policy issues as well as aspects related to research priorities and dissemination of research outputs are amongst the bottlenecks affecting the practical use of plant biotechnology research in South Africa.
Technological factors
Despite major advances in the development of plant tissue culture technology, a number of technical bottlenecks including physiological and developmental problems are still experienced today. One of the main technical challenges in clonal micropropagation is somaclonal variation (reviewed by Bairu et al., 2011b) . According to Bairu et al. (2011b) , somaclonal variation is one of the most researched and reviewed topics in plant tissue culture, thus indicating the severity of the problem in plant biotechnology applications. Another technical factor that has attracted research attention in many laboratories is hyperhydricity. Recently, Bairu et al. (2007) suggested the use of meta-topolins as a possible remedy against the negative effects of hyperhydricity. Alternatively, Snyman et al. (2011a Snyman et al. ( , 2011b alleviated hyperhydricity in sugarcane plantlets by using the RITA® immersion system and manipulating various culture conditions such as nutrients, sucrose levels and immersion regimes. In addition, in vitro shoot-tip necrosis has also plagued plant tissue culture applications, in particular micropropagation of woody species (reviewed by Bairu et al., 2009) .
The ultimate goal in the biotechnology of medicinal plants for secondary metabolites is the scaling-up from research laboratories to large-scale industrial production (Guillon et al., 2006; Matkowski, 2008) . However, despite cell cultures having been established for many plants, the potential offered by the 'plant cell factory' has had only limited commercial success due to several technical bottlenecks such as low productivity and bioprocess engineering challenges (Shanks and Morgan, 1999; Oksman-Caldentey and Inze', 2004) . Currently, bioreactor technology remains relatively expensive thereby affecting scaling-up potential for industrial production of secondary metabolites. One option to circumvent the high capital costs of bioprocess technology is to increase productivity several-fold, hence the need for more research and development efforts in this regard. The interest of industry in the 'plant cell factory' concept will probably continue to energise research efforts so as to adapt the model to new scales and diverse objectives (Guillon et al., 2006) . Research into the fundamentals of biosynthetic pathways and the regulatory mechanisms controlling plant secondary metabolism will expand our understanding of their synthesis and facilitate the precise manipulation of biochemical processes for increased productivity.
Socioeconomic factors
Inadequate infrastructures for scaling-up bioreactor technology, lack and/or loss of skilled human resources, as well as the cost of technology development and transfer (Fennell and Van Staden, 2004) are amongst the major constraints still facing the applications of plant biotechnology in South Africa. It was acknowledged in the National Biotechnology Strategy for South Africa (DST, 2001 ) that a lack of adequate expertise and skills is a major constraint in the application of biotechnology in South Africa. This situation is exacerbated by limited employment opportunities for graduates in the academic and industrial sectors resulting in a general lack of interest in this field, coupled with lack of adequate or sustainable project running costs. Although interventions such as an active international recruitment programme and establishment of remuneration packages competitive with those on international markets have been suggested (DST, 2001) as measures for the development and retention of human resources for biotechnology, more is required to implement this strategy and reverse the current trend from 'brain drain' to 'brain gain'. The creation of more biotechnology regional innovation centres (now absorbed into TIA), an intervention recommended in the National Biotechnology Strategy, could promote the development of skilled human resources for biotechnological advances and application.
Plant biotechnology companies are characterized by the need for multiple rounds of funding until they become self-sustainable. A key limiting factor for the development and expansion of the plant biotechnology sector in South Africa is lack of sufficient start-up funding or investment capital. This obstacle is described as 'the single biggest obstacle' to realising the potential of plant biotechnology (Sherwin, 2006) . Biotechnology companies in South Africa receive less funding compared to those in America and Europe. This makes the initial establishment as well as market competition and sustainability in technology advancement difficult. This is possibly why there are not many plant biotechnology business sectors or enterprises in South Africa translating the research endeavours to economic value. The DST, during the past nine years or so, has put a commendable initiative in place to bridge the gap between research and commercialization by supporting a number of research projects in plant biotechnology through PlantBio (now absorbed into TIA). One notable example is the establishment of a plant tissue culture company in George supported by PlantBio. Unfortunately the success rate of such ventures cannot be accurately measured due to lack of information. In the presence of sound research endeavours and rich plant resources in South Africa; a more coordinated funding system would undoubtedly help overcome the economic challenges. A review of the biotechnology funding environment in South Africa has recently been provided (Pouris, 2008) .
Dissemination of research outputs
A search of the literature reveals that many micropropagation protocols have been developed for South African medicinal and/or ornamental plants (Table 1) . Most of these protocols however, end up in academic journals and the outputs often do not get to the end-users who have little or no access to these published articles. The increased pressure on academics to 'publish or perish' coupled with the performance appraisal mechanism (Cloete et al., 2006) often based on the number of published research articles has also resulted in research lacking market or commercial value. The desire to publish research articles in high-impact scientific journals has therefore become the major driving force in the scientific communities with less consideration for their commercialization or market value. Brink et al. (1998) recommended that a national biotechnology policy strategy be developed in each country for biotechnology development in Africa. A national biotechnology strategy was subsequently formulated in 2001 for South Africa. This strategy was developed to fill some identified gaps in the development and application of biotechnology in South Africa. Whilst some of the proposed interventions have been attended to, there is a constant need to review existing policy and legal framework in order not to hamper recent developments in the field of biotechnology being a rapidly evolving field (DST, 2001). A major policy boost is the recent South Africa Act (Intellectual Property Rights from Publicly Financed Research and Development Act No. 51 of 2008) which provides for the establishment of National Intellectual Property Management Office and the Intellectual Property Fund as well as the creation of Technology Transfer offices in higher education institutions. This Act, which ensures the provision of financial incentives to researchers in South Africa and required support for registering patents, could greatly facilitate the commercialization of plant biotechnology research outputs. More awareness programmes sensitising University researchers of the benefits need to be planned and implemented.
Policy issues

Research priorities
It is very crucial that plant biotechnology research focus on national needs if the technology is to be applied in a beneficial manner. A good collaboration network or linkage between endusers, industries and researchers could be helpful to scientists in applying biotechnological methods towards solving practical problems. Bornman et al. (2004) recommended that research efforts should not only be concentrated on large commodity crops to the point that less commercial indigenous species are neglected. Such indigenous species could be developed as new crops with a large commercial potential. In funding biotechnology research projects, close attention should be given to the relevance of the proposed project to the national/regional needs. There may also be a need for a paradigm shift when it comes to rewarding research productivity. More incentives may have to be given to research addressing immediate national needs. The development of low cost biotechnology options (International Atomic Energy Agency, 2004) and synthetic seeds would facilitate application of such technology by the end users.
Public perception and/or understanding of biotechnology
Despite the benefits and the incorporation of bio-safety regulations in the legal framework for biotechnology applications, the general population lacks the necessary scientific understanding of the basic principles involved in the development of some biotechnology products, e.g. genetically modified foods (GMO). Many plant gatherers and practitioners of traditional medicine are of the opinion that cultivated plant species (including micropropagated plants) do not contain essentially the same bioactive constituents (qualitatively and/or quantitatively) or healing power as their wild counterparts. Such kind of understanding results in an apathetic attitude towards biotechnology products. In order to address this challenge, the National Biotechnology Strategy for South Africa (2001) recommended two interventions, namely: (i) articulation of a single biotechnology vision, and (ii) promotion of public education about technology. The latter would include public campaigns and workshops (involving the media houses) as well as the incorporation of biotechnology-related matters in the school (primary to tertiary) curriculum. The establishment of Public Understanding of Biotechnology Programme under the Department of Science and Technology should be able to bridge the gap between the public and the benefits and application of biotechnology in South Africa.
Conclusions
Despite the many achievements and potentials of plant biotechnology in propelling economic development and alleviating poverty, amongst others, its industrial and commercial applications are still limited by a number of factors. In addition to the obvious economic factors, better understanding by government of research and its outcomes remains one of the key factors influencing the process. Thus, to successfully overcome these challenges, close cooperation between the key players involved in the research and development, and industrial application of biotechnology, including scientists, industry, policy makers, and the general public would be required.
The role of biotechnology in harnessing the economic potential of South African plants in the areas of floriculture, food, forestry, medicinal and pharmaceutical secondary metabolites remains indispensable to humanity. Over the past few decades, a myriad of plant biotechnology innovations have been achieved in South Africa laying a firm foundation for future research and development endeavours. Other growing research areas involving plant tissue culture techniques in South Africa include synthetic seed technology, molecular farming (biopharming) and bioreactor technology for secondary metabolite production. These rapidly growing fields of plant biotechnology research offer immense possibilities in long and short-term conservation, micropropagation and production of pharmaceutical proteins.
Further advancements in the development and application of plant tissue culture-based technologies will require urgent solutions to problems such as somaclonal variation, hyperhydricity and shoot-tip necrosis. A better understanding and elucidation of the underlying biochemical and molecular mechanisms regulating cellular metabolic pathways may eventually provide long-lasting solutions to these and other physiological challenges encountered in plant tissue culture applications. apologies to authors whose work is not cited to keep the manuscript brief.
